CSIMarket
 
Soligenix inc   (NASDAQ: SNGX)
 

Soligenix Inc's Suppliers Performance

SNGX's Supply Chain




 
SNGX Costs vs Sales of Suppliers Growth

• More on SNGX Suppliers






Soligenix Inc's Comment on Supply Chain


The company outsources drug substance and drug product manufacturing to qualified third-party suppliers and does not maintain its own manufacturing facilities. It has agreements with third-party manufacturers for the production of bulk drug substances, as well as for formulation, packaging, and distribution of its product candidates. Currently, all drug substances are manufactured by single suppliers, with formulation and distribution also handled by single suppliers. The company recognizes the limited number of manufacturers and the challenges associated with transferring technology to alternative suppliers. Existing supply agreements cover development stages only, and secondary suppliers will be qualified upon obtaining marketing approval. Additionally, the company has an agreement with SciClone, which granted access to SciClone's oral mucositis clinical and regulatory data library in exchange for exclusive commercialization rights for SGX942 in China, including Hong Kong.

Soligenix Inc's Comment on Supply Chain


The company outsources drug substance and drug product manufacturing to qualified third-party suppliers and does not maintain its own manufacturing facilities. It has agreements with third-party manufacturers for the production of bulk drug substances, as well as for formulation, packaging, and distribution of its product candidates. Currently, all drug substances are manufactured by single suppliers, with formulation and distribution also handled by single suppliers. The company recognizes the limited number of manufacturers and the challenges associated with transferring technology to alternative suppliers. Existing supply agreements cover development stages only, and secondary suppliers will be qualified upon obtaining marketing approval. Additionally, the company has an agreement with SciClone, which granted access to SciClone's oral mucositis clinical and regulatory data library in exchange for exclusive commercialization rights for SGX942 in China, including Hong Kong.







SNGX's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Soligenix inc 6.16 0.85 -9.95 14
SUBTOTAL 0.00 0.00 0.00 -


Sources: Soligenix inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Soligenix inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.